Budesonide Extended-Release Capsules and Dolutegravir 25 mg and 50 mg
Determining the interaction of Budesonide Extended-Release Capsules and Dolutegravir 25 mg and 50 mg and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: budesonide
Brand name: Entocort EC, Uceris, Pulmicort Flexhaler, Pulmicort Respules
Synonyms: Budesonide, Budesonide (Oral Inhalation)
Generic Name: dolutegravir
Brand name: Tivicay
Synonyms: Dolutegravir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Budesonide Extended-Release Capsules-Dolutegravir and lamivudine
- Budesonide Extended-Release Capsules-Dolutegravir and rilpivirine
- Budesonide Extended-Release Capsules-Dolutegravir Sodium
- Budesonide Extended-Release Capsules-Dolutegravir Sodium And Lamivudine
- Budesonide Extended-Release Capsules-Dolutegravir Sodium and Rilpivirine Hydrochloride
- Budesonide Extended-Release Capsules-Dom-Etoposide
- Dolutegravir 25 mg and 50 mg-Budesonide Extended-Release Tablets
- Dolutegravir 25 mg and 50 mg-Budesonide inhalation
- Dolutegravir 25 mg and 50 mg-Budesonide Inhalation Powder
- Dolutegravir 25 mg and 50 mg-Budesonide Inhalation Suspension
- Dolutegravir 25 mg and 50 mg-Budesonide nasal
- Dolutegravir 25 mg and 50 mg-Budesonide Nasal Spray